There are 203 resources available
2025: The year for modified TCRs for solid tumours
Presenter: Victor Moreno Garcia
Session: Cell therapies in solid tumours
Resources:
Slides
Webcast
The patient perspective
Presenter: Bettina Ryll
Session: Investigator initiated trials: The osmosis with sponsors, regulators, trialists
Resources:
Slides
Webcast
The view of the cooperative groups
Presenter: Denis Lacombe
Session: Investigator initiated trials: The osmosis with sponsors, regulators, trialists
Resources:
Slides
Webcast
Q&A and discussion
Session: Cell therapies in solid tumours
Resources:
Webcast
Panel discussion
Session: Investigator initiated trials: The osmosis with sponsors, regulators, trialists
Resources:
Webcast
Why do we need to understand PK curves, halflives and AUCs in early drug development?
Presenter: Shelby Barnett
Session: Workshop in collaboration with ESMO YOC: Basics on PKs
Resources:
Slides
Webcast
Do we need to adjust dosing of oncolytics for young, elderly, obese, bariatric surgery, … patients?
Presenter: Tim Schutte
Session: Workshop in collaboration with ESMO YOC: Basics on PKs
Resources:
Slides
Webcast
Q&A and discussion
Session: Workshop in collaboration with ESMO YOC: Basics on PKs
Resources:
Webcast
Welcome and introduction
Presenter: Alessandra Gennari
Session: ESMO Colloquium supported by Novartis - Radiotheranostics in oncology: Optimising the science, building capacity and streamlining the regulation
Resources:
Slides
Webcast
Clinical drug development of radiotheranostics: Trial design, administered vs absorbed dose and the role of internal dosimetry
Presenter: Alessandra Gennari
Session: ESMO Colloquium supported by Novartis - Radiotheranostics in oncology: Optimising the science, building capacity and streamlining the regulation
Resources:
Slides
Webcast